debrisoquin has been researched along with sulfamethazine in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (25.00) | 18.7374 |
1990's | 10 (62.50) | 18.2507 |
2000's | 1 (6.25) | 29.6817 |
2010's | 1 (6.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Henschel, L; Hoffmann, A | 1 |
Henschel, L; Hoffmann, A; Sigusch, H | 1 |
Barry, M; Feely, J; Holland, P | 1 |
Henschel, L; Hoffmann, A; Huster, A; Jorke, D; Kraul, H; Reinhardt, M; Töpfer, R; Truckenbrodt, J | 1 |
Jiang, WD; Xu, XM | 1 |
Heafield, MT; Steventon, GB; Sturman, S; Waring, RH; Williams, AC | 1 |
Idle, JR; Karakaya, AE; Sardaş, S | 1 |
Baumann, P; Bosshart, P; Gabris, G; Gastpar, M; Koeb, L; Woggon, B | 1 |
Acharya, VN; Kshirsagar, NA; Pohujani, SM; Satoskar, RS; Takle, MR | 1 |
Boutagy, J; Peart, GF; Shenfield, GM | 1 |
Baumgarten, R; Eike, E; Eike, O; Fengler, JD; Franke, G; Siegmund, W; Zschiesche, M | 1 |
Harland, CC; Marsden, JR; Steventon, GB | 1 |
Hoffmann, A; Lautenschlager, MT; Müller, UA; Viktor, S | 1 |
Gawrońska-Szklarz, B; Górnik, W; Kunicki, P; Pawlik, A; Sitkiewicz, D; Sych, Z; Wójcicki, J | 1 |
1 trial(s) available for debrisoquin and sulfamethazine
Article | Year |
---|---|
[Comparison of serum concentrations of caffeine, 4-methylaminoantipyrine, sulfamethazine and debrisoquin following oral administration of these substances as a cocktail in type II diabetics before and after insulin therapy].
Topics: Adult; Aged; Anti-Infective Agents; Caffeine; Central Nervous System Stimulants; Cytochrome P-450 Enzyme System; Debrisoquin; Diabetes Mellitus, Type 2; Dipyrone; Drug Combinations; Female; Humans; Hypoglycemic Agents; Insulin; Isoenzymes; Male; Middle Aged; Pyrazolones; Sulfamethazine; Sympatholytics | 1996 |
15 other study(ies) available for debrisoquin and sulfamethazine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[Assessment of biotransformation capacity following oral administration of various model substances as cocktail].
Topics: Acetylation; Administration, Oral; Adult; Biotransformation; Caffeine; Cytochrome P-450 Enzyme System; Debrisoquin; Dipyrone; Humans; Hydroxylation; Liver; Male; Phenotype; Sulfamethazine | 1991 |
[The effects of verapamil and nifedipine on the biotransformation of model substances and on the indocyanine green elimination].
Topics: Adult; Biotransformation; Caffeine; Debrisoquin; Dipyrone; Humans; Indocyanine Green; Liver; Liver Circulation; Male; Nifedipine; Sulfamethazine; Verapamil | 1991 |
Pharmacogenetics and drug metabolism: an Irish perspective.
Topics: Acetylation; Adult; China; Debrisoquin; Humans; Ireland; Metabolism; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Sulfamethazine | 1991 |
[Simultaneous administration of various model substances for characterizing in vivo biotransformation in chronic liver diseases].
Topics: Biotransformation; Caffeine; Debrisoquin; Dipyrone; Fatty Liver, Alcoholic; Female; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis, Alcoholic; Liver Diseases, Alcoholic; Liver Function Tests; Male; Metabolic Clearance Rate; Sulfamethazine | 1990 |
Debrisoquine hydroxylation and sulfamethazine acetylation in a Chinese population.
Topics: Acetylation; Adolescent; Adult; Asian People; China; Chromatography, High Pressure Liquid; Debrisoquin; Female; Humans; Hydroxylation; Male; Phenotype; Sulfamethazine | 1990 |
Xenobiotic metabolism in Alzheimer's disease.
Topics: Acetaminophen; Adolescent; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Carbocysteine; Debrisoquin; Female; Humans; Male; Methyltransferases; Middle Aged; Sulfamethazine; Xenobiotics | 1990 |
Are the traits for drug acetylation and oxidation co-inherited?
Topics: Acetylation; Adult; Debrisoquin; Female; Genes, Recessive; Humans; Isoquinolines; Male; Middle Aged; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Sulfamethazine | 1988 |
Acetylation of maprotiline and desmethylmaprotiline in depressive patients phenotyped with sulfamidine, debrisoquine, and mephenytoin.
Topics: Acetylation; Anthracenes; Debrisoquin; Depressive Disorder; Gas Chromatography-Mass Spectrometry; Humans; Maprotiline; Mephenytoin; Phenotype; Sulfamethazine | 1988 |
Sulphadimidine acetylation status in Gujarati and Marathi population.
Topics: Acetylation; Adult; Debrisoquin; Female; Gene Frequency; Humans; India; Male; Middle Aged; Phenotype; Sulfamethazine | 1987 |
Debrisoquine oxidation in an Australian population.
Topics: Acetylation; Adolescent; Adult; Australia; Debrisoquin; Female; Genetic Variation; Humans; Isoquinolines; Male; Middle Aged; Oxidation-Reduction; Phenotype; Sulfamethazine; Urine; White People | 1986 |
[Genetic polymorphism in Gilbert-Meulengracht syndrome (GMS)].
Topics: Acetylation; Arylamine N-Acetyltransferase; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Debrisoquin; Gilbert Disease; Humans; Hydroxylation; Metabolic Clearance Rate; Mixed Function Oxygenases; Phenotype; Polymorphism, Genetic; Sulfamethazine | 1993 |
Thalidomide-induced neuropathy and genetic differences in drug metabolism.
Topics: Acetylation; Adrenergic Agents; Adult; Anti-Infective Agents; Debrisoquin; Dermatologic Agents; Female; Humans; Male; Neural Conduction; Peripheral Nervous System Diseases; Sulfamethazine; Thalidomide | 1995 |
N-acetylation and hydroxylation polymorphisms in type II diabetics with microvascular disturbances.
Topics: Acetylation; Adult; Aged; Debrisoquin; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gene Frequency; Humans; Hydroxylation; Male; Middle Aged; Phenotype; Polymorphism, Genetic; Sulfamethazine | 1997 |